Longitude Capital Management Co., LLC
Longitude Prime Fund, L.P.
Follow-ons only
Follow-ons only: no first sale reported; age from Form D filed Jun 2021 (approximate)
- Vintage
- Unknown
- Fund size
- $130M to $141.91M (Form D and SEC adviser filing)
- Stages
- Growth
- Sectors
- Biotech, Medical devices, Healthtech
- Regions
- Not stated
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$4.33M to $8.87M (estimated from fund size)
Estimated from Form D and SEC adviser filing
03 · Who to approach
Named on this fund's Form D
- Juliet Tammenoms Bakker, Managing Member of the General Partner
- Patrick Enright, Managing Member of the General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideLongitude Capital specializes in making venture growth investments in biotechnology, medical technology, and health solutions companies that seek to improve clinical outcomes, enhance patient quality of life, and reduce the cost of care.
Longitude Capital specializes in making venture growth investments in biotechnology, medical technology, and health solutions companies that seek to improve clinical outcomes, enhance patient quality of life, and reduce the cost of care.
https://www.longitudecapital.com/
06 · Sources
Last verified: Oct 28, 2026